Uvadex
Payments companies reported to CMS as associated with Uvadex. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Uvadex, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Uvadex
These are the largest totals companies reported as associated with Uvadex. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Oleg Akilov | Pittsburgh, PA | Dermatology | $92,101.40 |
| Ahmed Galal | Morristown, NJ | Hematology (Internal Medicine) | $68,331.84 |
| Daniel Aires | Kansas City, KS | Dermatology | $63,312.86 |
| Anthony Fernandez | Cleveland, OH | Dermatology | $49,366.83 |
| Kelly Mccaul | Sioux Falls, SD | Hematology & Oncology | $34,541.90 |
| Donna Griebel | Lawrence, KS | Internal Medicine | $30,387.50 |
| Amin Alousi | Houston, TX | Internal Medicine | $14,305.40 |
| Stanley Jordan | West Hollywood, CA | Nephrology (Internal Medicine) | $13,750.00 |
| Amber Sanchez | San Diego, CA | Nephrology (Internal Medicine) | $13,008.05 |
| Alain Rook | Philadelphia, PA | Dermatology | $11,817.38 |
Prescribed Uvadex?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.